Literature DB >> 9268733

Sodium butyrate induces NIH3T3 cells to senescence-like state and enhances promoter activity of p21WAF/CIP1 in p53-independent manner.

H Xiao1, T Hasegawa, O Miyaishi, K Ohkusu, K i Isobe.   

Abstract

Sodium butyrate, a histone deacetylase inhibitor, has been shown to induce differentiation of many cancer cells and senescence-like state of human fibroblasts. Here we show that sodium butyrate also induces senescence-like state of NIH3T3 cells. The treated cells were blocked at G1 phase and featured morphologically like senescent cells with enlarged cytoplasm and multiple nuclei. The expression of p21(WAF/CIP1) (p21) increased after sodium butyrate treatment at transcriptional level. To analyze the induction of promoter activity, we isolated 4.6 kb of murine p21 promoter and inserted it upstream of a luciferase reporter gene. When this construct was transiently transfected into NIH3T3 cells, sodium butyrate enhanced the luciferase activity. p53 independency of sodium butyrate-inducible p21 promoter activity was confirmed by using the deletion mutants lacking p53 binding sites and p53 deficient cells in transfection experiments.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9268733     DOI: 10.1006/bbrc.1997.7158

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  14 in total

1.  Sp1 and chromatin environment are important contributors to the formation of repressive chromatin structures on the transfected human adenine nucleotide translocase-2 promoter.

Authors:  Z Hodny; R Li; P Barath; B D Nelson
Journal:  Biochem J       Date:  2000-02-15       Impact factor: 3.857

2.  Characterization of the activities of p21Cip1/Waf1 promoter-driven reporter systems during camptothecin-induced senescence-like state of BHK-21 cells.

Authors:  Hsueh-Ling Cheng; Shiou-Ming Chang; Ya-Wen Cheng; Hung-Jen Liu; Yo-Chia Chen
Journal:  Mol Cell Biochem       Date:  2006-05-24       Impact factor: 3.396

3.  Lhx4 deficiency: increased cyclin-dependent kinase inhibitor expression and pituitary hypoplasia.

Authors:  Peter Gergics; Michelle L Brinkmeier; Sally A Camper
Journal:  Mol Endocrinol       Date:  2015-02-10

4.  GATA-1 directly regulates p21 gene expression during erythroid differentiation.

Authors:  Michael Papetti; Sandeep N Wontakal; Tomas Stopka; Arthur I Skoultchi
Journal:  Cell Cycle       Date:  2010-05-15       Impact factor: 4.534

5.  Iron chelation-induced senescence-like growth arrest in hepatocyte cell lines: association of transforming growth factor beta1 (TGF-beta1)-mediated p27Kip1 expression.

Authors:  Gyesoon Yoon; Hyun-Jung Kim; Young-Sil Yoon; Hyeseong Cho; In K Lim; Jae-Ho Lee
Journal:  Biochem J       Date:  2002-09-01       Impact factor: 3.857

6.  CUDC-101, a Novel Inhibitor of Full-Length Androgen Receptor (flAR) and Androgen Receptor Variant 7 (AR-V7) Activity: Mechanism of Action and In Vivo Efficacy.

Authors:  Huiying Sun; Sanjay N Mediwala; Adam T Szafran; Michael A Mancini; Marco Marcelli
Journal:  Horm Cancer       Date:  2016-03-08       Impact factor: 3.869

7.  Natural variants of hepatitis B virus X protein have differential effects on the expression of cyclin-dependent kinase inhibitor p21 gene.

Authors:  Hyun Jin Kwun; Kyung Lib Jang
Journal:  Nucleic Acids Res       Date:  2004-04-23       Impact factor: 16.971

8.  The histone deacetylase inhibitor SAHA arrests cancer cell growth, up-regulates thioredoxin-binding protein-2, and down-regulates thioredoxin.

Authors:  Lisa M Butler; Xianbo Zhou; Wei-Sheng Xu; Howard I Scher; Richard A Rifkind; Paul A Marks; Victoria M Richon
Journal:  Proc Natl Acad Sci U S A       Date:  2002-08-20       Impact factor: 11.205

9.  Effects of 5-azacytidine and butyrate on differentiation and apoptosis of hepatic cancer cell lines.

Authors:  X M Wang; X Wang; J Li; B M Evers
Journal:  Ann Surg       Date:  1998-06       Impact factor: 12.969

10.  The ability of antigen, but not interleukin-2, to promote n-butyrate-induced T helper 1 cell anergy is associated with increased expression and altered association patterns of cyclin-dependent kinase inhibitors.

Authors:  Stephanie K Jackson; Annick DeLoose; Kathleen M Gilbert
Journal:  Immunology       Date:  2002-08       Impact factor: 7.397

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.